CN1178110A - Medicine for lung cancer - Google Patents
Medicine for lung cancer Download PDFInfo
- Publication number
- CN1178110A CN1178110A CN 96118359 CN96118359A CN1178110A CN 1178110 A CN1178110 A CN 1178110A CN 96118359 CN96118359 CN 96118359 CN 96118359 A CN96118359 A CN 96118359A CN 1178110 A CN1178110 A CN 1178110A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- rhizoma
- lung cancer
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A series of medicines including oral medicine, refined oral medicine and exterior-used medicine for curing lung cancer is prepared from more than 50 Chinese-medicinal materials such as arisaema tuber, oldenlandia, loquat leaf, houttuynia, peach leaf, etc. and features notable curative effect and no toxic by-effect.
Description
Medicine for lung cancer of the present invention relates to the Chinese herbal and crude drugs preparations with the vegetable material preparation, is a kind of Chinese herbal medicine that is used for the treatment of pulmonary carcinoma.
As everyone knows, the sickness rate of pulmonary carcinoma is classified the first place as in all cancers, and cure rate then is a low level.Western medical treatment pulmonary carcinoma only limits to delay the development of disease, and a kind of control that disease is carried out temporarily is in case the disease burst is even use whole skills, also of no avail.Moreover doctor trained in Western medicine is also big to the side effect of human body, even disease is temporarily controlled, normal cell is then wrecked simultaneously in the right health, finally still is difficult to flee from misfortune.Because the toxin of cancer is anything but merely on " cancer " word, but be five lung six internal organs.
The present invention is intended to overcome the side effect that western medicine therapy produces the human normal cell, thereby provides a kind of safe and effective, and the Chinese herbal medicine that As the medicine took effect, the symptoms lessened reaches the purpose of effecting a radical cure pulmonary carcinoma.
Technical scheme of the present invention system adopts three kinds of medicaments to be finished: promptly adopt respectively No. 1, No. 2 and No. 3 medicine for lung cancer are a course of therapy medicament, wherein No. 1 oral medicine of medicine for lung cancer comprises following composition:
Rhizoma Arisaematis, Radix Saposhnikoviae, Radix Glycyrrhizae, Rhizoma Pinelliae Preparata, Folium Persicae, Fructus Trichosanthis, Bulbus Fritillariae Uninbracteatae, Semen Armeniacae Amarum, Radix Platycodonis, Pseudobulbus Cremastrae Seu Pleiones, Fructus Arctii, Flos Lonicerae, Indigo Naturalis, Herba Hedyotidis Diffusae, Caulis Spatholobi, the Radix Astragali, Radix Codonopsis, Rhizoma Smilacis Glabrae, the Rhizoma Atractylodis Macrocephalae, Pericarpium Citri Reticulatae, Radix Adenophorae (Radix Glehniae), Radix Ophiopogonis, Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Radix Scrophulariae, Spica Prunellae, the Pseudobulbus Bletillae (Rhizoma Bletillae), Herba Houttuyniae, Radix Sophorae Tonkinensis, Herba Solani Lyrati, Cortex Lycii, Rhizoma Imperatae, Cortex Moutan, Lasiosphaera Seu Calvatia, Radix Sophorae Flavescentis, Rhizoma Polygonati, Herba Taraxaci, Rhizoma Paridis, Herba Scutellariae Barbatae, Herba Salviae Chinensis, Rabdosia rubescens, Fructus Ligustri Lucidi, Semen Plantaginis, Folium Artemisiae Argyi, Radix Scutellariae.Can add the five tastes, Pheretima, Folium Eriobotryae after 15 days, and remove Herba Houttuyniae, Radix Sophorae Flavescentis, Radix Scutellariae, wherein No. 2 refining oral medicine of medicine for lung cancer comprise following composition: Rhizoma Saururi (Herba Saururi), Squama Manis, Radix Notoginseng, Cordyceps, Radix Panacis Quinquefolii, wherein No. 3 medicine for lung cancer application compress comprise following composition: Folium Eriobotryae, Radix Notoginseng, Folium Persicae, the Pseudobulbus Bletillae (Rhizoma Bletillae), pollen, Rhizoma Paridis, Fructus Gardeniae, Bulbus Lycoridis Radiatae, Plumbum preparatium, Borneolum Syntheticum.
The present invention below is described in detail in detail: the medicament that use each course of treatment is respectively three kinds of models: the prescription of each model medicament of following division:
1., No. 1 oral medicine of medicine for lung cancer:
Rhizoma Arisaematis 3-5g Fructus Arctii 5-6g
Radix Saposhnikoviae 4-6g Flos Lonicerae 9-11g
Radix Glycyrrhizae 6-8g Indigo Naturalis 4-6g
Rhizoma Pinelliae Preparata 4-6g Herba Hedyotidis Diffusae 9-11g
Folium Persicae 4-6g Caulis Spatholobi 9-11g
Fructus Trichosanthis 4-6g Radix Astragali 9-11g
Bulbus Fritillariae Uninbracteatae 4-6g Radix Codonopsis 9-11g
Semen Armeniacae Amarum 4-6g Rhizoma Smilacis Glabrae 14-16g
Radix Platycodonis 3-5g Rhizoma Atractylodis Macrocephalae 4-6g
Pseudobulbus Cremastrae Seu Pleiones 4-6g Pericarpium Citri Reticulatae 9-11g
Radix Adenophorae (Radix Glehniae) 4-6g Radix Sophorae Flavescentis 3-5g
Radix Ophiopogonis 4-6g Rhizoma Polygonati 9-11g
Radix Salviae Miltiorrhizae 5-7g Herba Taraxaci 9-11g
Radix Paeoniae Rubra 4-6g Rhizoma Paridis 1-3g
Radix Scrophulariae 9-11g Herba Scutellariae Barbatae 4-6g
Spica Prunellae 4-6g Herba Salviae Chinensis 9-11g
Pseudobulbus Bletillae (Rhizoma Bletillae) 9-11g Rabdosia rubescens 4-6g
Herba Houttuyniae 9-11g Fructus Ligustri Lucidi 4-6g
Radix Sophorae Tonkinensis 4-6g Semen Plantaginis 4-6g
Herba Solani Lyrati 9-11g Folium Artemisiae Argyi 4-6g
Cortex Lycii 4-6g Radix Scutellariae 4-6g
Rhizoma Imperatae 9-11g Cortex Moutan 4-6g
Lasiosphaera Seu Calvatia 4-6g
Add five tastes 4-6g after 15 days again, Pheretima 3-5g, Folium Eriobotryae 9-11g removes Herba Houttuyniae, Radix Sophorae Flavescentis and Radix Scutellariae.
2., No. 2 refining oral medicine of medicine for lung cancer:
Rhizoma Saururi (Herba Saururi) 4-6g Cordyceps 3-5g
Squama Manis 3-5g Radix Panacis Quinquefolii 3-5g
Radix Notoginseng 3-5g
3., the medicine for lung cancer 3 extra drug of topical application:
Folium Eriobotryae 28-32g Bulbus Lycoridis Radiatae 18-22g
Folium Persicae 28-32g Plumbum preparatium 3-7g
Pollen 18-22g Borneolum Syntheticum 3-7g
Rhizoma Paridis 4-6g Radix Notoginseng 8-12g
Fructus Gardeniae 13-17g Pseudobulbus Bletillae (Rhizoma Bletillae) 18-22g
The making of No. 1 oral medicine of above-mentioned medicine for lung cancer and No. 2 refining oral medicine of medicine for lung cancer is all made to dry to grind into powder.The making of the medicine for lung cancer 3 extra drug of topical application is ground into powder to dry earlier, and reuse Folium Artemisiae Argyi 18-22g fries in shallow oil the water mediation and makes.The person is not advisable with cold compress bitterly, and pain person is advisable with hot compress.Apply day and stop night, apply and stop day night, potion on the one spreads on chest.
Medicine for lung cancer of the present invention is evident in efficacy, does not have any secondary toxic action, and can get the effect of radical cure.
Claims (2)
1, medicine for lung cancer system is made by multiple Chinese herbal medicine, it is characterized in that the present invention gives complete by three kinds of dosage forms, be No. 1 oral medicine of medicine for lung cancer, No. 2 refining oral medicine of medicine for lung cancer, the medicine for lung cancer 3 extra drug of topical application, three kinds of dosage forms are all with pulverizing, blending preparation patent medicine, and their prescription is as follows respectively:
1. No. 1 oral medicine of medicine for lung cancer:
Rhizoma Arisaematis 3-5g Fructus Arctii 5-6g
Radix Saposhnikoviae 4-6g Flos Lonicerae 9-11g
Radix Glycyrrhizae 6-8g Indigo Naturalis 4-6g
Rhizoma Pinelliae Preparata 4-6g Herba Hedyotidis Diffusae 9-11g
Folium Persicae 4-6g Caulis Spatholobi 9-11g
Fructus Trichosanthis 4-6g Radix Astragali 9-11g
Bulbus Fritillariae Uninbracteatae 4-6g Radix Codonopsis 9-11g
Semen Armeniacae Amarum 4-6g Rhizoma Smilacis Glabrae 14-16g
Radix Platycodonis 3-5g Rhizoma Atractylodis Macrocephalae 4-6g
Pseudobulbus Cremastrae Seu Pleiones 4-6g Pericarpium Citri Reticulatae 9-11g
Radix Adenophorae (Radix Glehniae) 4-6g Radix Sophorae Flavescentis 3-5g
Radix Ophiopogonis 4-6g Rhizoma Polygonati 9-11g
Radix Salviae Miltiorrhizae 5-7g Herba Taraxaci 9-11g
Radix Paeoniae Rubra 4-6g Rhizoma Paridis 1-3g
Radix Scrophulariae 9-11g Herba Scutellariae Barbatae 4-6g
Spica Prunellae 4-6g Herba Salviae Chinensis 9-11g
Pseudobulbus Bletillae (Rhizoma Bletillae) 9-11g Rabdosia rubescens 4-6g
Herba Houttuyniae 9-11g Fructus Ligustri Lucidi 4-6g
Radix Sophorae Tonkinensis 4-6g Semen Plantaginis 4-6g
Herba Solani Lyrati 9-11g Folium Artemisiae Argyi 4-6g
Cortex Lycii 4-6g Radix Scutellariae 4-6g
Rhizoma Imperatae 9-11g Cortex Moutan 4-6g
Lasiosphaera Seu Calvatia 4-6g
2. No. 2 refining oral medicine of medicine for lung cancer:
Rhizoma Saururi (Herba Saururi) 4-6g Cordyceps 3-5g
Squama Manis 3-5g Radix Panacis Quinquefolii 3-5g
Radix Notoginseng 3-5g
3. the medicine for lung cancer 3 extra drug of topical application:
Folium Eriobotryae 28-32g Bulbus Lycoridis Radiatae 18-22g
Folium Persicae 28-32g Plumbum preparatium 3-7g
Pollen 18-22g Borneolum Syntheticum 3-7g
Rhizoma Paridis 4-6g Radix Notoginseng 8-12g
Fructus Gardeniae 13-17g Pseudobulbus Bletillae (Rhizoma Bletillae) 18-22g
2, according to the described medicine for lung cancer of claim 1, it is characterized in that No. 1 oral medicine of medicine for lung cancer adds five tastes 4-6g again after using 15 days, Pheretima 3-5g, Folium Eriobotryae 9-11g removes Herba Houttuyniae, Radix Sophorae Flavescentis and Radix Scutellariae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96118359 CN1178110A (en) | 1996-09-28 | 1996-09-28 | Medicine for lung cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96118359 CN1178110A (en) | 1996-09-28 | 1996-09-28 | Medicine for lung cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1178110A true CN1178110A (en) | 1998-04-08 |
Family
ID=5125028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 96118359 Pending CN1178110A (en) | 1996-09-28 | 1996-09-28 | Medicine for lung cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1178110A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1074292C (en) * | 1999-05-19 | 2001-11-07 | 赵国民 | Cancer treating medicine capsule |
| CN1318073C (en) * | 2004-09-27 | 2007-05-30 | 上海市胸科医院 | Chinese medicine compound preparation for treating lung cancer |
| CN101085269B (en) * | 2007-06-08 | 2010-06-16 | 马海明 | Internal-applied traditional Chinese medicine composition for treating lung cancer |
| CN101152262B (en) * | 2007-09-25 | 2011-05-25 | 邱日辉 | Anti-gout novel medical preparation |
| CN103169746A (en) * | 2013-03-21 | 2013-06-26 | 中国中医科学院广安门医院 | Traditional Chinese medicine composition for treating lung cancer |
| CN103417872A (en) * | 2013-08-19 | 2013-12-04 | 王锦生 | TCM composition for treatment of lung cancer and preparation method thereof |
| CN103495025A (en) * | 2013-10-06 | 2014-01-08 | 张洪胜 | Traditional Chinese medicine preparation for treating pulmonary fibrosis |
-
1996
- 1996-09-28 CN CN 96118359 patent/CN1178110A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1074292C (en) * | 1999-05-19 | 2001-11-07 | 赵国民 | Cancer treating medicine capsule |
| CN1318073C (en) * | 2004-09-27 | 2007-05-30 | 上海市胸科医院 | Chinese medicine compound preparation for treating lung cancer |
| CN101085269B (en) * | 2007-06-08 | 2010-06-16 | 马海明 | Internal-applied traditional Chinese medicine composition for treating lung cancer |
| CN101152262B (en) * | 2007-09-25 | 2011-05-25 | 邱日辉 | Anti-gout novel medical preparation |
| CN103169746A (en) * | 2013-03-21 | 2013-06-26 | 中国中医科学院广安门医院 | Traditional Chinese medicine composition for treating lung cancer |
| CN103417872A (en) * | 2013-08-19 | 2013-12-04 | 王锦生 | TCM composition for treatment of lung cancer and preparation method thereof |
| CN103495025A (en) * | 2013-10-06 | 2014-01-08 | 张洪胜 | Traditional Chinese medicine preparation for treating pulmonary fibrosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1124153C (en) | Medicinal composition for restoring cardiac collaterals and its application | |
| CN100356972C (en) | Chinese medicine for treating amblyopia and myopia | |
| CN1375298A (en) | Pain-relieving notoginseng mixture | |
| CN1100651A (en) | Chinese herbal prepn. for curing chronic gastroenteritis and peptic gastric ulcer | |
| CN1485083A (en) | Capsule for thyroid cancer / tumor and lymph node | |
| CN103230548B (en) | Traditional Chinese medicine composition for treating pulmonary heart disease | |
| CN101028481A (en) | Medicinal liquor for treating hyperosteogency and koilorrhachic | |
| CN1091609C (en) | Tincture for treating rheumatoid arthritis and its preparing process | |
| CN1103223C (en) | Chinese medicine for treating cholecystitis | |
| CN103550506A (en) | Traditional Chinese medicine composition cooperatively used in radiotherapy | |
| CN1178110A (en) | Medicine for lung cancer | |
| CN1539441A (en) | Compounded medicine for anti pathogeny and immunoenhancement | |
| CN1186687A (en) | Cancer preventing curing medicine series and its preparation | |
| CN1317315A (en) | Tendon-comfortable analgesic | |
| CN1160560A (en) | Chinese patent drug for curing leukopenia and its preparation process | |
| CN1058911A (en) | The compound method of capsule for curing tumour | |
| CN1141114C (en) | Tendon-conditioning analgetic | |
| CN1698863A (en) | Chinese medicine preparation for treating hyperosteogeny | |
| CN100518800C (en) | Medicinal composition for treating hepatitis B | |
| CN1181879C (en) | Analgestic plaster | |
| CN1377672A (en) | Rheumatic pain killing preparation | |
| CN1279943C (en) | Chinese medicine for treating brain disease | |
| CN1298724A (en) | Medicine for treating immunodefiiciency disease | |
| CN1177489A (en) | Chines medicine for treating vitiligo and preparation method thereof | |
| CN1104542A (en) | Health-care Chinese medicine bag |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |